Ushbu ish iqtibos qilgan ishlar

25 ta ish

Ish: Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries

Home visits: a strategy to improve newborn survival - Authors' reply
Kirkwood, B, Humphrey, J, Moulton, L +1
Maqola200821 iqtibos
ABI
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin +26
Maqola20208 iqtibos
ABI
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Denis Y. Logunov, Inna V. Dolzhikova, Dmitry V. Shcheblyakov +28
Maqola20215 iqtibos
ABI
Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
Derek K. Chu, Elie A Akl, Stephanie Duda +39
Sharh maqola20204 iqtibos
ABI
Recombinant vaccines for COVID-19
Tushar Yadav, Nishant Srivastava, Gourav Mishra +4
Sharh maqola20203 iqtibos
ABI
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi +97
Maqola20203 iqtibos
ABI
International Ethical Guidelines for Health-related Research involving Humans
Council for International Organizations of Medical Sciences (CIOMS)
Hisobot20163 iqtibos
ABI
The ethics of ‘public understanding of ethics’—why and how bioethics expertise should include public and patients’ voices
Silke Schicktanz, Mark Schweda, Brian Wynne
Maqola20112 iqtibos
ABI
Opinion summarization methods: Comparing and extending extractive and abstractive approaches
Roque López, Thiago Alexandre Salgueiro Pardo
Maqola20172 iqtibos
ABI
Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention
Sarah M. Bartsch, Kelly J. O’Shea, Marie C. Ferguson +8
Maqola20202 iqtibos
ABI
Good reasons to vaccinate: mandatory or payment for risk?
Julian Savulescu
Maqola20202 iqtibos
ABI
COVID-19 response in central Asia
Vijay Shankar Balakrishnan
Maqola20202 iqtibos
ABI
Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination
Roy M. Anderson, Carolin Vegvari, James E. Truscott +1
Maqola20202 iqtibos
ABI
Ethical allocation of future COVID-19 vaccines
Rohit Gupta, Stephanie R. Morain
Maqola20202 iqtibos
ABI
COVID-19 mortality risk assessment: An international multi-center study
Dimitris Bertsimas, Galit Lukin, Luca Mingardi +16
Maqola20202 iqtibos
ABI
Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access
Lisa Herzog, Ole Frithjof Norheim, Ezekiel Emanuel +1
Maqola20212 iqtibos
ABI
Just allocation of COVID-19 vaccines
Anders Herlitz, Zohar Lederman, Jennifer Miller +5
Maqola20212 iqtibos
ABI
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
Olivier J. Wouters, Kenneth C. Shadlen, Maximilian Salcher‐Konrad +4
Sharh maqola20212 iqtibos
ABI
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
Robert Challen, Ellen Brooks‐Pollock, Jonathan M. Read +3
Maqola20212 iqtibos
ABI
WHO’s allocation framework for COVAX: is it fair?
Siddhanth Sharma, Nisrine Kawa, Apoorva Gomber
Maqola20212 iqtibos
ABI
How long does covid-19 immunity last?
Chris Baraniuk
Maqola20212 iqtibos
ABI
Sarlavhasiz
Boshqa1 iqtibos
ABI
Sarlavhasiz
Boshqa1 iqtibos
ABI
Sarlavhasiz
Boshqa1 iqtibos
ABI
Sarlavhasiz
Boshqa1 iqtibos
ABI